glp-1 therapy metairie Healthy Weight Loss Medication Program Weight Management | GLP-1 Medical
Description
The Phase 3 ATTAIN-1 trial had good results that led to this approval, but not all positive: 12.4% average weight loss (27.3 lbs) at highest dose Lower than the 15-20% weight loss seen with injectables Wegovy and Zepbound Nearly 1/4 of participants on the highest dose reported vomiting Vomiting rates are much higher than injectable GLP-1s However, there is likely a niche for Foundayo (along with the pill version of Wegovy) due to convenience: No refrigeration requirements or injection site reactions Eliminates barriers for patients avoiding injectables due to stigma, needle aversion, or storage constraints It's possible we could see this as a "maintenance" therapy after an initial injectable course

Understanding how GLP1s work is an important step in deciding whether these medications align with your longterm health goals

Key pathways, including Wnt/-catenin, bone morphogenetic protein 2/Smad, phosphoinositide 3-kinase/Akt and protein kinase A, play a role in this

GLP-1 drops Oral Drops GLP-1 Drops are a prescription medication used to support blood sugar control in adults with type 2 diabetes

FDA Concerns Surrounding Compounded GLP-1 In a May 16, 2025 statement, the U.S
Low-income Californians who use Wegovy and similar medications for weight loss lost their coverage at the start of the new year, with officials advising diet and exercise instead
